Pituitary & hypothalamus

Prevalence and Associated Risk Factors for Venous Thromboembolism in a Large Cohort of Patients With Cushing Disease

Endocr PractPublished Retrospective cohort study

Authors' conclusion

The findings of this study confirm a high prevalence of VTE events in patients with CD, irrespective of the surgical period. Risk factors associated with a higher likelihood of VTE include obesity, severity of hypercortisolism, and the occurrence of postoperative complications. In this patient population, thromboprophylaxis should be considered.

Study context

Population
Patients with Cushing disease (CD) at a tertiary care center; controls with clinically nonfunctioning pituitary macroadenomas undergoing similar surgery
Participants
408 vs 323
Exposure
CD vs clinically nonfunctioning pituitary adenomas
  • CDn = 408
  • Nonfunctioning pituitary adenoman = 323reference
Outcome
Prevalence of VTE
Methodological detailssingle-centre, tertiary care center, control group of nonfunctioning pituitary macroadenomas
  • Single-centre
  • Tertiary care center
  • Control group of nonfunctioning pituitary macroadenomas

Main finding

As reported in the abstract

VTE events

P < 0.001

Observational data: associations, not effects.

Further findings

Timing of venous thromboembolism (VTE) events · preoperative period

VTE events occurring in the preoperative period
54%

Risk factors for VTE (logistic regression)

Significant risk factors: obesity, mood disorders, supraclavicular fossa fullness, leukopenia or leukocytosis, elevated serum and 24-hour urinary cortisol, postoperative complications (infections, cerebrospinal fluid leak, AVP deficiency)

Original publication

Prevalence and Associated Risk Factors for Venous Thromboembolism in a Large Cohort of Patients With Cushing Disease. Endocr Pract. Published 15 October 2025. doi:10.1016/j.eprac.2025.10.005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.